Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dichloromethane | HCID 6344 | — |
| Reactant | o-Bis(bromomethyl)benzene | HCID 66665 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | HCID 22914303 | HCID 22914303 | — |
| Product | HCID 70077018 | HCID 70077018 | 32% |
Reaction Steps
A suspension of 328 mg (1.0 mmol) of 3-(3-aminomethyl-1,2,4-oxadiazol-5-yl)-8-fluoro-5-methyl-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one in 5 ml of methylene chloride was treated under argon with 0.38 ml (2.2 mmol) of N-ethyldiisopropylamine and 317 mg (1.2 mmol) of α,α'-dibromo-o-xylene and stirred at room temperature under argon for 5 hrs. The solution was washed once with 5 ml of water, dried with sodium sulfate, filtered and evaporated. The crude product was purified by chromatography on 30 g of silica gel (methylene chloride/acetone 4:1, then 2:1). The eluates were evaporated and the residue was taken up in 2.5 ml of methanol. The solution was acidified with ethereal hydrochloric acid and the solvent was removed in a vacuum. The residue was taken up in 6 ml of hot methanol; then cooled to about 0° and the white crystals were isolated by suction filtration. There were obtained 150 mg (32%) of 8-fluoro-3-(3-isoindolin-2-ylmethyl-1,2,4-oxadiazol-5-yl)-5-methyl-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one hydrochloride (1:1) of m.p. 229°-233° (dec.).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05665718 |
|---|
| Source dataset | uspto-grants-1997_09 |
|---|
| ORD ID | ord-89f27428facc4bd6aa4deebf20cbab12 |
|---|
| Source note | uspto-grants-1997_09 |
|---|